Early research (Phase 1)Study completedNCT02055716What this trial is testingSulforadex in Healthy Human Males MADWho this might be right forProstate Cancer Evgen Pharma 18
Early research (Phase 1)Active Not RecruitingNCT03401385What this trial is testingFirst-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)Who this might be right forHormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung Cancer Daiichi Sankyo Co., Ltd. 890
Large-scale testing (Phase 3)WithdrawnNCT02100618What this trial is testingAntibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary StudyWho this might be right forInfections, Papillomavirus GlaxoSmithKline
Early research (Phase 1)Study completedNCT00185848What this trial is testingAssessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid ArthritisWho this might be right forBrain CancerArthritis, RheumatoidCentral Nervous System Neoplasms+1 more Sanjiv Sam Gambhir 10
Not applicableStudy completedNCT01767597What this trial is testingApplication of HBV Rapid Tests as a Tool for Wide-Use ScreeningWho this might be right forHepatitis BLiver CirrhosisCarcinoma, Hepatocellular Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 1,000
Early research (Phase 1)Study completedNCT02945215What this trial is testingAssess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma PatientsWho this might be right forB-Cell Lymphoma Innovent Biologics (Suzhou) Co. Ltd. 181
Early research (Phase 1)Study completedNCT04257617What this trial is testingA Trial of ZL-1201 in Subjects With Advanced CancerWho this might be right forAdvanced Cancer Zai Lab (Shanghai) Co., Ltd. 37
Testing effectiveness (Phase 2)Ended earlyNCT04066790What this trial is testingPyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast CancerWho this might be right forBreast Cancer Shanghai Jiao Tong University School of Medicine 12
Not applicableStudy completedNCT03542513What this trial is testingFirst-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)Who this might be right forCervical Cancer Universiteit Antwerpen 65
Large-scale testing (Phase 3)Active Not RecruitingNCT06635447What this trial is testingCapivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese PatientsWho this might be right forBreast Cancer AstraZeneca 293
Early research (Phase 1)Looking for participantsNCT07159126What this trial is testingDS3610a in Participants With Advanced Solid TumorWho this might be right forSolid TumorsMetastatic Solid Tumors Daiichi Sankyo 70
Not applicableStudy completedNCT00178308What this trial is testingMeasuring Alterations of DNA in Human BloodWho this might be right forNeoplasms University of Rochester 24
Testing effectiveness (Phase 2)Looking for participantsNCT05419089What this trial is testingThe Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)Who this might be right forHPV-positive Oropharyngeal Squamous Cell Carcinoma Icahn School of Medicine at Mount Sinai 83
Post-approval studies (Phase 4)UnknownNCT04356118What this trial is testingEfficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal MetastasisWho this might be right forLeptomeningeal Metastasis Hui Bu 30
Early research (Phase 1)Not Yet RecruitingNCT07797907What this trial is testingThis Clinical Study is to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Antitumor Activity of BD200 in Participants With Advanced or Metastatic Cancer.Who this might be right forSolid Tumor (Phase I) Biolojic Design Ltd. 110
Early research (Phase 1)Active Not RecruitingNCT04898634What this trial is testingJNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate CancerWho this might be right forProstatic Neoplasms Janssen Research & Development, LLC 216
Testing effectiveness (Phase 2)Study completedNCT00585650What this trial is testingStudy of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or FeetWho this might be right forPsoriasis University of California, Irvine 20
Testing effectiveness (Phase 2)Study completedNCT01513278What this trial is testingStudy of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast CancerWho this might be right forRadiation Induced Dermatitis Apeiron Biologics 20
Large-scale testing (Phase 3)Study completedNCT00144482What this trial is testingRecombinant Human Erythropoietin in Anemic Cancer Patients Undergoing ChemotherapyWho this might be right forChemotherapy Induced Anemia Chugai Pharmaceutical 122
Testing effectiveness (Phase 2)Study completedNCT00258960What this trial is testingCaelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Spanish Breast Cancer Research Group 49